HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study

NACompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 7, 2019

Primary Completion Date

May 8, 2020

Study Completion Date

October 30, 2020

Conditions
STEMI - ST Elevation Myocardial InfarctionNSTEMI - Non-ST Segment Elevation MI
Interventions
DIAGNOSTIC_TEST

Helicobacter Pylori screening by UBT

The UBT is based on the fact that Hp produces urease, which catalyzes the urea molecule into ammonia (NH3) and carbon dioxide (CO2). After fasting for six hours prior to testing, the patient swallows a C13 Urea tablet or solution and waits. After 10 minutes, the patient exhales and breath is collected (tube, bag or breath card). The production of 13CO2 is measured by a desktop analyzer (infrared mass spectrometry) and Hp diagnosis is made based on previously established cut-off levels for Hp infection.

Trial Locations (2)

11883

Södersjukhuset, Stockholm

14157

Karolinska University Hospital Huddinge, Huddinge

All Listed Sponsors
lead

Karolinska Institutet

OTHER

NCT04289012 - HELicobacter Pylori Screening in Patients With Acute Myocardial Infarction Pilot Study | Biotech Hunter | Biotech Hunter